| Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment J Park, Y Choi, H Chang, W Um, JH Ryu, IC Kwon Theranostics 9 (26), 8073, 2019 | 254 | 2019 |
| Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy MK Shim, J Park, HY Yoon, S Lee, W Um, JH Kim, SW Kang, JW Seo, ... Journal of controlled release 294, 376-389, 2019 | 120 | 2019 |
| Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy S Lim, J Park, MK Shim, W Um, HY Yoon, JH Ryu, DK Lim, K Kim Theranostics 9 (25), 7906, 2019 | 103 | 2019 |
| Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity S Yang, MK Shim, WJ Kim, J Choi, GH Nam, J Kim, J Kim, Y Moon, ... Biomaterials 272, 120791, 2021 | 89 | 2021 |
| Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex J Park, JU Choi, K Kim, Y Byun Biomaterials 147, 145-154, 2017 | 69 | 2017 |
| Current limitations and recent progress in nanomedicine for clinically available photodynamic therapy J Park, YK Lee, IK Park, SR Hwang Biomedicines 9 (1), 85, 2021 | 64 | 2021 |
| Caspase-3/-7-specific metabolic precursor for bioorthogonal tracking of tumor apoptosis MK Shim, HY Yoon, S Lee, MK Jo, J Park, JH Kim, SY Jeong, IC Kwon, ... Scientific reports 7 (1), 16635, 2017 | 59 | 2017 |
| Dual-modal imaging-guided precise tracking of bioorthogonally labeled mesenchymal stem cells in mouse brain stroke S Lim, HY Yoon, HJ Jang, S Song, W Kim, J Park, KE Lee, S Jeon, S Lee, ... ACS nano 13 (10), 10991-11007, 2019 | 58 | 2019 |
| Functional transformations of bile acid transporters induced by high-affinity macromolecules TA Al-Hilal, SW Chung, F Alam, J Park, KE Lee, H Jeon, K Kim, IC Kwon, ... Scientific reports 4 (1), 4163, 2014 | 55 | 2014 |
| Oligomeric bile acid-mediated oral delivery of low molecular weight heparin TA Al-Hilal, J Park, F Alam, SW Chung, JW Park, K Kim, IC Kwon, IS Kim, ... Journal of controlled release 175, 17-24, 2014 | 55 | 2014 |
| Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy W Um, J Park, H Ko, S Lim, HY Yoon, MK Shim, S Lee, YJ Ko, MJ Kim, ... Biomaterials 224, 119494, 2019 | 54 | 2019 |
| Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo S Lee, S Jung, H Koo, JH Na, HY Yoon, MK Shim, J Park, JH Kim, S Lee, ... Biomaterials 148, 1-15, 2017 | 54 | 2017 |
| NLRP3 ubiquitination—a new approach to target NLRP3 inflammasome activation M Akther, ME Haque, J Park, TB Kang, KH Lee International Journal of Molecular Sciences 22 (16), 8780, 2021 | 46 | 2021 |
| Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex J Kim, G Shim, H Choi, J Park, SW Chung, S Kim, K Kim, IC Kwon, ... Biomaterials 33 (17), 4424-4430, 2012 | 45 | 2012 |
| Regulation of caspase-8 activity at the crossroads of pro-inflammation and anti-inflammation JH Han, J Park, TB Kang, KH Lee International Journal of Molecular Sciences 22 (7), 3318, 2021 | 36 | 2021 |
| The molecular mechanism of polyphenols with anti-aging activity in aged human dermal fibroblasts JH Lee, J Park, DW Shin Molecules 27 (14), 4351, 2022 | 34 | 2022 |
| A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway JU Choi, SW Chung, TA Al-Hilal, F Alam, J Park, F Mahmud, JH Jeong, ... Biomaterials 139, 56-66, 2017 | 29 | 2017 |
| Targeting prion-like protein doppel selectively suppresses tumor angiogenesis TA Al-Hilal, SW Chung, JU Choi, F Alam, J Park, SW Kim, SY Kim, ... The Journal of clinical investigation 126 (4), 1251-1266, 2016 | 27 | 2016 |
| Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF165 J Park, J Kim, SR Hwang, F Mahmud, Y Byun Molecular pharmaceutics 12 (11), 3935-3942, 2015 | 27 | 2015 |
| Potentiation of anti-angiogenic activity of heparin by blocking the ATIII-interacting pentasaccharide unit and increasing net anionic charge SW Chung, M Lee, SM Bae, J Park, OC Jeon, HS Lee, H Choe, HS Kim, ... Biomaterials 33 (35), 9070-9079, 2012 | 26 | 2012 |
